Core Viewpoint - Manulife Fund, the first public fund management company in China to transition from a joint venture to a wholly foreign-owned enterprise, celebrates its third anniversary as a wholly foreign-owned entity, emphasizing its commitment to the Chinese market and the future of pension finance [2][4]. Group 1: Company Achievements - Over the past three years, Manulife Fund has added 13 million new clients, with total assets under management reaching approximately 100 billion yuan, reflecting a 52% increase since the full acquisition [5][6]. - The company's active stock investment capability ranks 6th out of 127 fund companies in the past two years, and 11th out of 98 in the past five years [5][6]. Group 2: Strategic Focus - Manulife Fund aims to leverage its global resources and local insights to provide innovative wealth and asset management solutions, focusing on three core areas: active management, global asset allocation, and pension finance [4][9]. - The company has established three differentiated core advantages: leading active management capability, global asset allocation ability, and a deep understanding of local pension finance needs [8][9]. Group 3: Pension Finance Initiatives - Manulife Fund collaborates with various partners to explore pension solutions tailored to Chinese residents, including reports and products aimed at addressing retirement needs [6][12]. - The company actively participates in the first batch of floating rate fund trials in China and has launched green financial products in response to national carbon reduction goals [6][12]. Group 4: Future Outlook - The company is optimistic about the Chinese pension market, anticipating significant opportunities due to demographic changes and the need for a strengthened pension system [8][9]. - Manulife Fund is committed to becoming a key player in the high-quality development of the pension industry, emphasizing the importance of collaboration among all stakeholders in the pension ecosystem [13][15].

Core Viewpoint - The approval of fund products is undergoing a counter-cyclical adjustment mechanism to better protect investor interests, with a more cautious approach towards new equity fund approvals due to high valuation benchmarks [2][4][11]. Group 1: Regulatory Adjustments - Regulatory scrutiny has increased for new equity funds, requiring that the performance benchmark index's rolling valuation over the last five years be below the historical 90th percentile and the last three months below the 80th percentile [5][6]. - The approval process has been optimized, with a focus on sectors with relatively low valuations, such as healthcare, food, and consumer electronics [5][6]. Group 2: Market Behavior and Fund Management - Despite a bullish A-share market, fund companies are exercising restraint in new equity fund launches, with many setting initial fundraising caps at 2 billion to 3 billion yuan [2][9]. - A significant number of new equity funds launched this year have set fundraising limits, with 57% of these limits below 3 billion yuan [9]. Group 3: Investor Experience and Fund Performance - The industry is shifting from a focus on scale to quality, aiming to enhance investor experience and long-term returns [11]. - Fund companies are implementing measures such as subscription limits and dynamic allocation to ensure fair investment experiences for all investors [9][11]. Group 4: Long-term Investment Ecosystem - The deepening implementation of the counter-cyclical adjustment mechanism is expected to attract more long-term capital into the public fund industry, enhancing investor satisfaction [11]. - The regulatory framework is evolving to emphasize long-term performance and investor returns, moving away from traditional metrics like scale and revenue [9][11].

Core Viewpoint - The article highlights the implementation of the first employee stock ownership plan (ESOP) by Yongying Fund following the release of the "Action Plan for Promoting High-Quality Development of Public Funds" [2][6]. Group 1: Employee Stock Ownership Plan - Yongying Fund has added three limited partnership enterprises as shareholders, collectively holding 3.51% of the equity, transferred from Oversea-Chinese Banking Corporation Limited [4][5]. - This marks Yongying Fund as the first fund company to implement an employee stock ownership plan after the release of the "Action Plan" [6]. Group 2: Fund Growth and Performance - Yongying Fund has experienced rapid growth, with total assets exceeding 620 billion yuan, and non-monetary assets reaching 428.93 billion yuan, an increase of nearly 78 billion yuan since the beginning of the year [8]. - The fund's product structure is balanced, with nearly 180 fund products, equally divided between fixed income and equity products [8]. - The company emphasizes strategic restraint despite rapid growth, stating that scale is a result of capability rather than a goal [8].

Core Viewpoint - TaLong Pharmaceutical's controlling shareholder is planning to transfer company shares, which may lead to a change in control. The company's stock has been suspended from trading since December 2, 2025, for a period not exceeding two trading days [2][4]. Group 1: Shareholder Information - The controlling shareholder, Zhengzhou TaiRong Industrial Investment Co., Ltd. (TaiRong Investment), holds 82,441,168 shares, accounting for 14.37% of the total shares [9][10]. - The actual controller of TaLong Pharmaceutical is the Zhengzhou High-tech Industrial Development Zone Management Committee, which holds 98.17% of Zhengzhou High-tech Investment Holding Group Co., Ltd. [10]. Group 2: Business Overview - TaLong Pharmaceutical's main business includes drug manufacturing and research services, covering four segments: drug formulation, traditional Chinese medicine pieces, drug research services, and drug material circulation [9]. Group 3: Financial Performance - For the first three quarters, TaLong Pharmaceutical reported a revenue of 1.187 billion yuan, a year-on-year decrease of 11.47%. The net profit attributable to shareholders was 25.33 million yuan, down 12.36% year-on-year [12]. - The company's total revenue for the latest quarter was 1.187 billion yuan, with total costs of 1.167 billion yuan, resulting in an operating profit of 3.5 million yuan [13].

来源：政事儿综合 湖南日报、红网时刻新闻客户端 11月28日至29日，湖南省委十二届九次全会在长沙召开，省委书记沈晓明讲话。 据红网时刻新闻客户端12月1日报道， 湖南省委全会为两场同期举行的婚宴临时腾场地，成 了热议话题。 11月28日，湖南省委十二届九次全会第一次全体会议在湖南宾馆芙蓉厅召开。 原来，11月29日，湖南省委十二届九次全会第二次全体会议在湖南宾馆举行的时间，也是两 位新郎官曾先生和李先生不约而同挑选的好日子。湖南宾馆当天就接了3场婚宴。 11月29日，湖南省委十二届九次全会第二次全体会议在湖南宾馆会议中心三楼大会厅召开。图源：《湖南新闻联播》 据报道， 湖南宾馆是湖南历史最早的政务接待宾馆之一，长期承担省里的重要接待任务。近些 年来，虽一直在探索市场化路径，但做好省里重要活动的保障服务，仍是重中之重。 "得知省委全会确定在11月28日、29日召开，一方面我们及时通知预定在芙蓉厅举行婚礼的两 对新人，另一方面积极向上反映，申请将第二次全体会议会场调整到宾馆的会议中心三楼。" 湖南宾馆接待营销部经理陈英 说， 更换场地的申请获得了同意，"印象中这是第一次"。 11月29日中午，在芙蓉厅外等待入场 ...

【导读】蓝思科技独董谢志明因病逝世，董事会成员暂减至6名 中国基金报记者 忆山 12月1日，蓝思科技发布公告称，近日，公司独立董事谢志明不幸因病逝世。 资料显示，谢志明，1972年出生，会计学博士教授，博士生导师，中国注册会计师。2003年 9月以来，谢志明任长沙理工大学经济与管理学院副教授、MBA中心主任、教授；2015年至 2023年间，先后兼任湖南省财政厅管理会计咨询专家，湖南省人大财经委咨询专家，湖南省 科技厅项目评审专家以及国家社科基金委评审专家；2024年4月以来，兼任株洲九方装备股 份有限公司独立董事；同年12月，被提名为蓝思科技第五届董事会独立董事候选人。 蓝思科技表示，谢志明在担任公司董事会独立董事、审计委员会主任委员、薪酬与考核委员 会主任委员期间，恪尽职守，忠实、勤勉地履行了作为独立董事应尽的职责和义务，为公司 相关决策事项提供了专业意见和建议。公司及董事会对谢志明在任职期间所做贡献表示衷心 感谢。 谢志明逝世后，公司现任董事会成员由7名变为6名（独立董事和非独立董事各3名），未低于 法定最低人数，但低于《公司章程》规定的董事会成员人数。公司将根据有关规定，尽快按 照相关程序增补新的独立 ...

【导读】 创投行业这一年：LP出资回暖退出路径多元化渐成共识 中国基金报记者 莫琳 "年底正值绩效考核的关键期，我们投资者关系（IR）团队已连续多日高强度工作，为不同类 型的基金出资人（LP）量身定制募资方案，人手严重不足。"北京某头部创投机构的IR负责人 坦言。 据中国基金报记者了解，此前数年的"募资寒冬"已导致创投机构的募资团队经历了一轮持续 的优化与精简，今年市场环境显著回暖，LP的出资意愿普遍增强，但是，不同背景的LP核心 诉求各异，标准化的募资策略已然失效。上述IR负责人透露，其三人团队需同时推进三个新 LP的募资方案，并为八个存量LP准备年度基金运营总结。 无论是宏观数据还是微观体感，均表明中国私募股权行业已走出"募资寒冬"。伴随顶层设计 的调整，以私募股权二级市场基金（S基金）和并购基金为代表的多元化退出路径正日益获得 国资的青睐，为创投行业注入了新的活力。 LP出资回暖 国资成为市场"压舱石" 近日，FOFWEEKLY发布的《LP全景报告2025》揭示了市场稳健增长的态势。数据显示， 2025年前三季度，机构LP认缴出资规模已达1.24万亿元人民币，同比增长9%。鉴于第四季 度通常是政策型LP ...

【导读】华泰期货聘任周而立为总经理 中国基金报记者 晨曦 又有头部期货高管变更！ 12月1日盘后，华泰证券发布公告称，其全资子公司 华泰期货聘任周而立为总经理 ，董事长 赵昌涛不再兼任总经理。 对于此次周而立履新华泰期货总经理，业内此前已有预期。今年8月26日，中国期货业协会公 告，周而立通过了期货公司高管人员专业能力水平评价测试，拟任职务为华泰期货有限公司 总经理。 公开信息显示，周而立在华泰证券工作多年，曾任华泰证券常州分公司、北京分公司等分支 机构的负责人。2019年7月，周而立以"华泰证券北京分公司总经理"的身份参与华泰期货、 华泰证券联合主办的2019年投资策略暨股指期货风险管理报告会。另外，2022年8月，周而 立还以"华泰证券团委书记"的身份参加公开活动。 中国期货业协会信息显示，周而立在2025年9月成为华泰期货的董事，当前职务为华泰期 货"党委副书记、总经理"，登记日期为2025年10月15日。 校对：纪元 编辑：鹿米 审核： 许闻 注：本文封面图由AI生成 版权声明 《中国基金报》对本平台所刊载的原创内容享有著作权，未经授权禁止转载，否则将追究法律责任。 授权转载合作联系人：于先生（电话： ...

Core Viewpoint - Qianwei Yangchu is initiating a shareholder return program, offering a product gift package valued at 200 yuan to individual shareholders holding 100 shares or more as a gesture of appreciation for their support [1][3]. Group 1: Shareholder Return Program - The program is set to reward shareholders who are registered as of December 1, 2025, with individual shareholders eligible for one gift package and corporate shareholders eligible for three [3][5]. - The initiative aims to enhance shareholder understanding of the company's intrinsic value and product offerings [1][3]. Group 2: Company Overview - Qianwei Yangchu, known as the "first stock of prepared dishes in Henan," was listed on the Shenzhen Stock Exchange in September 2021, focusing on the development and production of semi-finished products for various clients, including major restaurant chains [5]. - The company reported a revenue of 4.92 billion yuan for Q3 2025, reflecting a year-on-year increase of 4.27%, while the total revenue for the first three quarters was 13.78 billion yuan, showing a modest growth of 1% [5][6]. - The net profit attributable to shareholders for the first three quarters was 53.78 million yuan, a significant decline of 34.06% year-on-year, with a similar decrease in net profit after excluding non-recurring items [5][6].

恒生指数重回26000点 12月1日，港股三大指数震荡收涨，恒生指数上涨0.67%，重回26000点大关之上；国企指 数、恒生科技指数分别上涨0.47%及0.82%。南向资金今日净流入21亿港元。 盘面上，大型科技股多数上涨；铜价、白银创新高，金价持续修复，有色板块大爆发。 | 恒生指数 | 恒生国企 | 恒生科技 | | --- | --- | --- | | 26033.26 | 9172.84 | 5644.76 | | +174.37 +0.67% | +42.66 +0.47% | +45.65 +0.82% | | 恒指期货 | 港股通50 | 恒生生物科技 | | 26056 | 3921.55 | 15694.29 | | +161 +0.62% | +21.31 +0.55% | +30.31 +0.19% | | 成交额2009亿 | | 南向资金净买入21亿 | 网易上涨近4%，阿里巴巴涨超2%，百度、腾讯、京东小幅分别上涨1.58%、1.31%、 0.52%。 【导读】恒生指数重回26000点大关；中兴通讯涨超13% 中国基金报记者 储是 港股迎来12月首日"开门红"行情，大型科技股、 ...